Jump Financial’s Rallybio RLYB Stock Holding History

Jump Financial’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,600	Closed	-$145K	–	1965
2022 Q1	$145K	Buy	+2,600	New	+$215K	0.01%	1367

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIIC

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Jump Financial's RLYB Position: Q2 2022 in Review

Jump Financial sold out of Rallybio (RLYB) in Q2 2022, closing a stake of 2,600 shares — an estimated $145K sold.

Jump Financial first reported a position in RLYB in Q1 2022 and held it in 1 quarter. The position peaked at $145K in Q1 2022. 47 funds tracked by Wall St. Rank hold RLYB as of Q2 2022.

Jump Financial reported no remaining Rallybio position as of Q2 2022 after selling out during the quarter.
Jump Financial sold 2,600 Rallybio shares in Q2 2022, an estimated $145K.
Jump Financial first reported a position in Rallybio in Q1 2022 and held it in 1 quarter.
Jump Financial's Rallybio position peaked at $145K in Q1 2022.
47 funds tracked by Wall St. Rank held Rallybio as of Q2 2022.

Based on Jump Financial's 13F filing for Q2 2022, filed 9 Aug 2022.